Sign in to view content

Baseline Factors Influencing Diabetic Macular Edema (DME) Resolution After Intravitreal Aflibercept Injection (IAI) or Laser Treatment in VISTA/VIVID

W. Lloyd Clark, MD, FASRS

Video
Published 2021

Related

Suprachoroidal CLS-TA Plus Aflibercept Compared With Aflibercept Monotherapy for DME: Results of a Phase 2 Trial
Michael S. Ip, MD
Annual Meeting Talks
2019
Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
Updates from the Field
2022
Outcomes of DRCR Network Treatment Regimen Starting With Observation for Eyes With Center-involved DME and Good Visual Acuity
Omar S. Punjabi, MD
Annual Meeting Talks
2019

Category: Diabetic Retinopathy

See more